['polycythemia vera']
['best available therapy', 'ruxolitinib']

        Inclusion Criteria:

        Confirmed diagnosis of PV according to the 2008 World Health Organization criteria,
        Non-palpable spleen, Phlebotomy dependent, Resistant to or intolerant of hydroxyurea, ECOG
        performance status of 0, 1 or 2.

        Exclusion Criteria:

        Inadequate liver or renal function, Significant bacterial, fungal, parasitic, or viral
        infection requiring treatment, Active malignancy within the past 5 years, excluding
        specific skin cancers, Previously received treatment with a JAK inhibitor, Being treated
        with any investigational agent, Women who are pregnant or nursing.

        Other inclusion/exclusion criteria apply.
      